BIOMERICA INC (BMRA) Stock Analyst Earnings Estimates
NASDAQ:BMRA - Nasdaq - US09061H3075 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 18.87M 162.08% | 5.34M -71.70% | 5.415M 1.40% | |
| EBITDA YoY % growth | -4.19M 43.07% | -7.14M -70.41% | -6.286M 11.96% | |
| EBIT YoY % growth | -4.53M 39.60% | -7.22M -59.38% | -6.367M 11.81% | |
| Operating Margin | -24.01% | -135.21% | -117.58% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | -0.09 25.00% | % | ||
| Q2 2023 Q2Q % growth | -0.12 -33.33% | % | ||
| Q1 2023 Q2Q % growth | -0.16 -33.33% | % | ||
| Q2 2022 Q2Q % growth | -0.09 30.77% | -0.08 | -0.01 | -10.29% |
| Q1 2022 Q2Q % growth | -0.12 14.29% | -0.12 | 0.00 | 1.96% |
| Q4 2021 Q2Q % growth | -0.12 -203.70% | -0.11 | -0.01 | -8.27% |
| Q3 2021 Q2Q % growth | -0.15 -66.67% | -0.08 | -0.07 | -83.82% |
| Q2 2021 Q2Q % growth | -0.13 -160.00% | -0.10 | -0.03 | -30.72% |
| Q1 2021 Q2Q % growth | -0.14 -180.00% | -0.08 | -0.06 | -71.57% |
| Q4 2020 Q2Q % growth | -0.04 50.00% | -0.07 | 0.03 | 41.18% |
| Q3 2020 Q2Q % growth | -0.09 -28.57% | -0.07 | -0.02 | -35.75% |
| Q2 2020 Q2Q % growth | -0.05 | -0.08 | 0.03 | 38.73% |
| Q1 2020 Q2Q % growth | -0.05 | -0.06 | 0.01 | 18.30% |
| Q4 2019 Q2Q % growth | -0.08 | -0.08 | 0.00 | 1.96% |
| Q3 2019 Q2Q % growth | -0.07 | -0.05 | -0.02 | -37.25% |
| Q2 2019 Q2Q % growth | -0.05 | -0.05 | 0.00 | 1.96% |
| Q1 2019 Q2Q % growth | -0.05 | -0.06 | 0.01 | 18.30% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 1.807M 5.67% | % | ||
| Q4 2024 Q2Q % growth | 1.116M 0.54% | % | ||
| Q3 2024 Q2Q % growth | 1.017M -8.38% | % | ||
| Q2 2024 Q2Q % growth | 1.57M 6.08% | % | ||
| Q1 2024 Q2Q % growth | 1.71M 4.27% | % | ||
| Q4 2023 Q2Q % growth | 1.11M -79.06% | % | ||
| Q3 2023 Q2Q % growth | 1.11M -85.51% | % | ||
| Q2 2023 Q2Q % growth | 1.48M -68.17% | % | ||
| Q1 2023 Q2Q % growth | 1.64M 30.16% | % | ||
| Q4 2022 Q2Q % growth | 5.3M 404.76% | % | ||
| Q3 2022 Q2Q % growth | 7.66M 111.02% | % | ||
| Q2 2022 Q2Q % growth | 4.65M 239.42% | 1.836M | 2.814M | 153.27% |
| Q1 2022 Q2Q % growth | 1.26M 10.53% | 1.938M | -678K | -34.98% |
| Q4 2021 Q2Q % growth | 1.05M -61.54% | 2.26M | -1.21M | -53.54% |
| Q3 2021 Q2Q % growth | 3.63M 207.63% | 1.447M | 2.183M | 150.86% |
| Q2 2021 Q2Q % growth | 1.37M -14.37% | 1.902M | -532K | -27.97% |
| Q1 2021 Q2Q % growth | 1.14M -4.20% | 1.221M | -81K | -6.63% |
| Q4 2020 Q2Q % growth | 2.73M 133.33% | 1.735M | 995K | 57.35% |
| Q3 2020 Q2Q % growth | 1.18M -6.35% | 1.382M | -202K | -14.62% |
| Q2 2020 Q2Q % growth | 1.6M 6.67% | 1.722M | -122K | -7.08% |
| Q1 2020 Q2Q % growth | 1.19M -6.30% | 1.546M | -356K | -23.03% |
| Q4 2019 Q2Q % growth | 1.17M | 1.548M | -378K | -24.42% |
| Q3 2019 Q2Q % growth | 1.26M | 1.614M | -354K | -21.93% |
| Q2 2019 Q2Q % growth | 1.5M | 1.566M | -66K | -4.21% |
| Q1 2019 Q2Q % growth | 1.27M | 1.455M | -185K | -12.71% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |